Cryo-Cell revenue was $31.15 m in FY, 2020
Cryo-Cell revenue breakdown by business segment: 97.4% from Umbilical Cord Blood and Cord Tissue Stem Cell Service and 2.6% from Other
|FY, 2019||FY, 2018||FY, 2017||FY, 2016|
|PrepaCyte CB||$172.4 k||$104.32 k||$442.19 k||$350.13 k|
|Umbilical Cord Blood and Cord Tissue Stem Cell Service||$30.99 m||$28.82 m||$24.94 m||$22.78 m|
|Public Cord Blood Banking||$652.2 k||$296.3 k|
Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.